A daily weight-loss pill could transform GLP-1 boom
1 min read
Image credit: Vidmir Raic via Pixabay. Article by Kelly Tyko and Nathan Bomey. Axios – April 17, 2025.
A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom.
Why it matters: Eli Lilly said on Thursday that its experimental pill — called orforglipron — is showing promising results and could serve as an alternative to blockbuster injectable medications like Ozempic and Mounjaro.
GLP-1s role in obesity fight
How it works: The appetite-suppressing drugs are called GLP-1 agonists and mimic the action of a hormone.
GOOG
IBM
AMZN
AAPL
DELL
INTC
MSFT
TSLA
META
EBAY
NVDA
NFLX
HPE
LUMN
ORCL